Possible role of macrophage-derived soluble mediators in the pathogenesis of encephalomyocarditis virus-induced diabetes in mice

Journal of Virology

Volumn 71, Issue 5, 1997, Pages 4024-4031

  Hirasawa, K ^a,b   Jun, H S ^a   Maeda, K ^b   Kawaguchi, Y ^b   Itagaki, S ^b   Mikami, T ^b   Baek, H S ^a   Doi, K ^b   Yoon, J W ^a,c  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF TOKYO   (Japan)

^c Ajou University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGUANIDINE; CYTOKINE; INTERLEUKIN 1BETA; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DIABETES MELLITUS; ENCEPHALOMYOCARDITIS VIRUS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MACROPHAGE ACTIVATION; MALE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL;

EID: 0030903103     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.5.4024-4031.1997     Document Type: Article

References (53)

1. Bae, Y. S., H. M. Eun, R. T. Pon, D. Giron, and J. W. Yoon. 1990. Two amino acids, Phe-16 and Ala-776, on the polyprotein are most likely responsible for diabetogenicity of EMC virus. J. Gen. Virol. 71:639-645.
2. Bae, Y. S., H. M. Eun, and J. W. Yoon. 1989. Genomic differences between the diabetogenic and non-diabetogenic variants of encephalomyocarditis virus. Virology 170:282-287.
3. Bae, Y. S., and J. W. Yoon. 1993. Determination of diabetogenicity attributable to a single amino acid, Ala-776, on the polyprotein of encephalomyocarditis virus. Diabetes 42:435-443.
4. Baek, H.-S., and J.-W. Yoon. 1990. Role of macrophages in the pathogenesis of encephalomyocarditis virus-induced diabetes in mice. J. Virol. 64:5708-5715.
5. Baek, H. S., and J. W. Yoon. 1991. Direct involvement of macrophages in destruction of β-cells leading to development of diabetes in virus-infected mice. Diabetes 40:1586-1597.
6. 1 and dietary lipid. Autoimmunity 13:141-149.
7. Bendtzen, K., T. Mandrup-Poulsen, J. Nerup, J. H. Nielsen, C. A. Dinarello, and M. Svenson. 1986. Cytotoxicity of human p17 interleukin-1 for pancreatic islets of Langerhans. Science 232:1545-1547.
8. G-monomethyl-L-arginine. FEBS Lett. 299:103-106.
9. Boucher, D. W., and A. L. Notkins. 1973. Virus-induced diabetes mellitus. I. Hyperglycemia and hypoinsulinemia in mice infected with encephalomyocarditis virus. J. Exp. Med. 137:1226-1239.
10. Bowman, M., O. Simell, Z. Look, R. Luchetta, and M. Atkinson. 1994. Pharmacokinetic and therapeutic analysis of aminoguanidine. Diabetes 43(Suppl. 1):235A.
11. Buschard, K., N. Hastrup, and J. Rygaard. 1983. Virus-induced diabetes in mice and thymus-dependent immune system. Diabetologia 24:42-46.
12. Buschard, K., J. Rygaard, and E. Lund. 1976. The inability of a diabetogenic virus to induce diabetes in athymic (nude) mice. Acta Pathol. Microbiol. Scand. Sect. C 84:299-303.
13. Campbell, I. L., A. Iscaro, and L. C. Harrison. 1988. IFN-γ and tumour necrosis factor-α: cytotoxicity to murine islets of Langerhans. J. Immunol. 141:2325-2329.
14. Campbell, I. L., L. Oxbrow, and L. C. Harrison. 1991. Reduction in insulitis following administration of IFN-γ and TNF-α in the NOD mouse. J. Autoimmun. 4:249-262.
15. Corbett, J. A., M. A. Sweetland, J. L. Wang, J. R. Lancaster, Jr., and M. L. McDaniel. 1993. Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans. Proc. Natl. Acad. Sci. USA 90: 1731-1735.
16. Corbett, J. A., and M. L. McDaniel. 1995. Intraislet release of interleukin 1 inhibits beta cell function by inducing beta cell expression of inducible nitric oxide synthase. J. Exp. Med. 181:559-568.
17. Craighead, J. E., and M. F. McLane. 1968. Diabetes mellitus: induction in mice by encephalomyocarditis virus. Science 162:913-915.
18. Eun, H. M., Y. S. Bae, and J. W. Yoon. 1988. Amino acid differences in the capsid protein, VP1, between diabetogenic and nondiabetogenic variants of encephalomyocarditis virus. Virology 163:369-373.
19. Faust, A., R. Kleemann, H. Rothe, and H. Kolb. 1996. Role of macrophages and cytokines in β-cell death, p. 47-56. In E. Shafrir (ed.), Lessons from animal diabetes VI. Birkhäuser Boston, Cambridge, Mass.
20. Han, H. S., H. S. Jun, T. Utsugi, and J. W. Yoon. 1996. A new type of CD4+ suppressor T cell completely prevents spontaneous autoimmune diabetes and recurrent diabetes in syngeneic islet-transplanted NOD mice. J. Autoimmun. 9:331-339.
21. Hayashi, K., W. Boucher, and A. L. Notkins. 1974. Virus-induced diabetes mellitus. II. Relationship between beta cell damage and hyperglycemia in mice infected with encephalomyocarditis virus. Am. J. Pathol. 75:91-102.
22. Hirasawa, K., M. Takeda, S. Itagaki, and K. Doi. 1996. Involvement of macrophages in the development of encephalomyocarditis virus (EMCV)-induced diabetes in mice. Exp. Anim. 45:77-80.
23. Hirasawa, K., S. Tsutsui, M. Takeda, M. Mizutani, S. Itagaki, and K. Doi. 1996. Depletion of Mac1-positive macrophages protects DBA/2 mice from encephalomyocarditis virus-induced myocarditis and diabetes. J. Gen. Virol. 77:737-741.
24. Jacob, C. O., S. Aiso, S. A. Michie, H. O. McDevitt, and H. Acha-Orbea. 1990. Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-α and interleukin 1. Proc. Natl. Acad. Sci. USA 87:968-972.
25. Kleemann, R., H. Rothe, V. Kolb-Bachofen, Q. W. Xie, C. Nathan, S. Martin, and H. Kolb. 1993. Transcription and translation of inducible nitric oxide synthase in the pancreas of prediabetic BB rats. FEBS Lett. 328:9-12.
26. Like, A. A., D. L. Guberski, and L. Butler. 1991. Influence of environmental viral agents on frequency and tempo of diabetes mellitus in BB/Wor rats. Diabetes 40:259-262.
27. W-nitro-L-arginine methyl ester reduces the incidence of IDDM in BB/E rats. Diabetes 44:365-368.
28. Mandrup-Poulsen, T., G. A. Spinas, S. J. Prowse, B. S. Hansen, D. W. Jorgensen, K. Bendtzen, J. H. Nielsen, and J. Nerup. 1987. Islet cytotoxicity of interleukin-1. Diabetes 36:641-647.
29. McDaniel, M. L., G. Kwon, J. R. Hill, C. A. Marshall, and J. A. Corbett. 1996. Cytokines and nitric oxide in islet inflammation and diabetes. Proc. Soc. Exp. Biol. Med. 211:24-32.
30. Onodera, T., J. W. Yoon, K. Brown, and A. L. Notkins. 1978. Virus-induced diabetes mellitus: evidence for control by a single locus. Nature 274:693-696.
31. Rossini, A. A., D. L. Greiner, H. P. Friedman, and J. P. Mordes. 1993. Immunopathogenesis of diabetes mellitus. Diabetes Rev. 1:43-75.
32. Rothe, H., K. Fehsel, and H. Kolb. 1990. Tumor necrosis factor alpha production is upregulated in diabetes prone BB rats. Diabetologia 33:573-575.
33. She, J. X. 1996. Susceptibility to type 1 diabetes: HLA-DQ and DR revisited. Immunol. Today 17:323-329.
34. Spinas, G. A., J. Mandrup-Poulsen, J. Mølvig, L. Baek, K. Bendtzen, C. A. Dinarello, and J. Nerup. 1986. Low concentrations of interleukin-1 stimulate and high concentrations inhibit insulin release from isolated rat islets of Langerhans. Acta Endocrinol. 113:551-558.
35. Spinas, G. A., B. S. Hansen, S. Linde, W. Kastern, J. Mølvig, T. Mandrup-Poulsen, C. A. Dinarello, J. H. Nielsen, and J. Nerup. 1987. Interleukin-1 dose-dependently affects the biosynthesis of (pro)insulin in isolated rat islets of Langerhans. Diabetologia 30:474-480.
36. Stuehr, D. J., S. S. Gross, I. Sakuma, R. Levi, and C. F. Nathan. 1989. Activated murine macrophages secrete a metabolite of arginine with the bioactivity of endothelium-derived relaxing factor and the chemical reactivity of nitric oxide. J. Exp. Med. 169:1011-1025.
37. Takeda, M., R. Miura, K. Shiota, K. Hirasawa, M. J. Lee, S. Itagaki, and K. Doi. 1995. Distribution of viral RNA in spinal cord of DBA/2 mice developing biphasic paralysis following with the D variant of encephalomyocarditis virus (EMC-D). Int. J. Exp. Pathol. 76:441-447.
38. Todd, J. A., and S. C. Bain. 1992. A practical approach to identification of susceptibility genes for IDDM. Diabetes 41:1029-1034.
39. Tschöpe, D., B. Schwippert, B. Schettler, U. Kiesel, H. Rothe, P. Roesen, and F. A. Gries. 1992. Increased GPIIB/IIIA expression and altered DNA-ploidy pattern in megakaryocytes of diabetic BB-rats. Eur. J. Clin. Invest. 22:591-598.
40. Vertrees, S., C. A. Wilson, R. Ubungen, D. Wilson, D. G. Baskin, B. Toivola, C. Jacobs, N. Boiani, P. Baker, and A. Lernmark. 1991. Interleukin-1β regulation of islet and thyroid autoimmunity in the BB rat. J. Autoimmun. 4:717-732.
41. Vialettes, B., D. Baume, C. Charpin, J. De Maeyer-Guignard, and P. Vague. 1983. Assessment of viral and immune factors in EMC virus-induced diabetes: effects of cyclosporin A and interferon. J. Clin. Lab. Immunol. 10:35-40.
42. Xie, Q. W., H. J. Cho, J. Calaycay, R. A. Mumford, K. M. Swiderek, T. D. Lee, A. Ding, T. Troso, and C. Nathan. 1992. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 256:225-228.
43. Yang, X. D., R. Tisch, S. M. Singer, Z. A. Cao, R. S. Liblau, R. D. Schreiber, and H. O. McDevitt. 1994. Effect of tumor necrosis factor α on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process. J. Exp. Med. 180:995-1004.
44. Yoon, J. W., M. M. Rodrigues, C. Currier, and A. L. Notkins. 1982. Long-term complications of virus-induced diabetes in mice. Nature 296:567-569.
45. Yoon, J. W., Y. H. Park, and P. Santamaria. 1995. Autoimmunity of insulin-dependent diabetes, p. 57-97. In C. Ioannides and P. R. Flatt (ed.), Drugs, diet and disease, vol. 2. Ellis Horwood, New York, N.Y.
46. Yoon, J. W. 1995. A new look at viruses in type I diabetes. Diabetes Metab. Rev. 11:83-107.
47. Yoon, J. W. 1996. Role of viruses in the pathogenesis of insulin-dependent diabetes mellitus, p. 339-349. In D. LeRoith, S. I. Taylor, and J. M. Olefsty (ed.), Diabetes mellitus: a fundamental and clinical text. Lippincott-Raven Publishers, Philadelphia, Pa.
48. Yoon, J. W., M. A. Lesniak, R. Fussganger, and A. L. Notkins. 1976. Genetic differences in susceptibility of pancreatic β-cells to virus-induced diabetes mellitus. Nature 264:178-180.
49. Yoon, J. W., P. R. McClintock, T. Onodera, and A. L. Notkins. 1980. Virus-induced diabetes mellitus. XVIII. Inhibition by a non-diabetogenic variant of encephalomyocarditis virus. J. Exp. Med. 152:878-892.
50. Yoon, J.-W., A. K. C. Wong, Y.-S. Bae, and H.-M. Eun. 1988. An apparent deletion of an oligonucleotide detected by RNA fingerprint in the nondiabetogenic B variant of encephalomyocarditis virus is caused by a point mutation. J. Virol. 62:637-640.
51. Yoon, J. W., and A. L. Notkins. 1976. Virus-induced diabetes mellitus. VI. Genetically determined host differences in the replication of encephalomyocarditis virus in pancreatic β-cells. J. Exp. Med. 143:1170-1179.
52. Yoon, J. W., and Y. S. Bae. 1993. A single gene of the host and a single amino acid of the virus can control the development of diabetes in animals, p. 51-60. In E. Shafrir (ed.), Frontiers in diabetes research: lessons from animal diabetes IV. Smith-Gordon, London, England.
53. Yoon, J. W., P. R. McClintock, C. J. Bachurski, J. D. Longstreth, and A. L. Notkins. 1985. Virus-induced diabetes mellitus: no evidence for immune mechanisms in the destruction of β-cells by the D-variant of encephalomyocarditis virus. Diabetes 34:922-925.